Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)

CUSIP: 185053402

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
2,174,400
Total 13F shares
601,206
Share change
-11,029
Total reported value
$5,451,442
Price per share
$1.04
Number of holders
6
Value change
-$30,388
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 185053402?
CUSIP 185053402 identifies CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Gotham Asset Management, LLC
13F
Company
16%
342,864
 $5,118,957 — 31 Dec 2024
13F
AdvisorShares Investments LLC
13F
Company
7.7%
167,856
 $231,641 — 31 Dec 2024
13F
Virtu Financial LLC
13F
Company
1.8%
39,479
 $54,000 — 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.8%
38,158
 $52,658 — 31 Dec 2024
13F
Cornerstone Wealth Group, LLC
13F
Company
0.92%
20,000
 $27,600 — 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
0.12%
2,564
 $3,538 — 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.04%
935
 $1,290 — 31 Dec 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
569
 $1,000 — 31 Dec 2024
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.02%
379
 $523 — 31 Dec 2024
13F

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) as of Q1 2025

As of 31 Mar 2025, Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 601,206 shares. The largest 6 holders included Gotham Asset Management, LLC, AdvisorShares Investments LLC, Cornerstone Wealth Group, LLC, TWO SIGMA SECURITIES, LLC, MORGAN STANLEY, and NATIONAL BANK OF CANADA /FI/. This page lists 6 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
9
Q1 2025 holders
6
Holder diff
-3
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .